France· FR:68080800
AETOXISCLEROL 3 % (60 mg/2 mL), solution injectable
A lauromacrogol 400 product, registered in France by KREUSSLER & CO ALLEMAGNE. The same ATC class is registered in 4 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
AETOXISCLEROL is registered in 4 of 19 countries.
Countries holding a registration under ATC Lauromacrogol 400 (lauromacrogol 400), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 2 of them publish a price we can compare per daily dose
AETOXISCLEROL · ATC Lauromacrogol 400
4 / 19 countries
- Franceprice
- Germany
- Spainprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Manufacturer
- KREUSSLER & CO ALLEMAGNE
- Country
- France (FR)
- ATC code
- Lauromacrogol 400
- ATC class
- Lauromacrogol 400
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 3
- cip1334009303119672 ampoule(s) en verre de 2 ml
- cip1334009303210652 ampoule(s) en verre de 2 mlL + kit de préparation de la mousse sclérosante de 1 seringue luer-lock non siliconée de 3 mL + une aiguille filtrante + 1 connecteur + 1 filtre
- cip1334009347753075 ampoule(s) en verre de 2 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
AETOXISCLEROL in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAethoxysklerol 30 mg/ml, oplossing voor injectieChemische Fabrik Kreussler & Co. GmbH
- FinlandAethoxysklerolOrifarm Oy
- United KingdomAethoxysklerol 10mg/2ml solution for injection ampoulesImported (Germany)
- BelgiumAethoxysklerol 0.5 %Chemische Fabrik Kreussler & Co
- PolandAethoxysklerol 0,5%Chemische Fabrik Kreussler Co.GmbH
- SpainETOXISCLEROL 10 MG/ML SOLUCION INYECTABLEChemische Fabrik Kreussler & Co Gmbh
- CzechiaAETHOXYSKLEROLChemische Fabrik Kreussler & Co., GmbH, Wiesbaden
- NorwayAethoxysklerolKreussler
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Aethoxysklerol, Recessan
- Belgium · Aethoxysklerol
- Czechia · Aethoxysklerol
- Germany · Aethoxysklerol, Anaesthesulf Lotio
- Denmark · Aethoxysklerol
- Spain · Etoxisclerol
- Finland · Aethoxysklerol
- United Kingdom (Northern Ireland) · Aethoxysklerol
- Hungary · Aethoxysklerol, Aethoxysklerol Oeso
- Italy · Atossisclerol
- Luxembourg · Aethoxysklerol
- Netherlands · Aethoxysklerol
- Poland · Aethoxysklerol, Aethoxysklerol 1% F
- Portugal · Etoxisclerol
- Sweden · Aethoxysklerol
- Slovakia · Aethoxysklerol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/85c29c90-959f-482b-bf49-293163126609 GET /v1/drugs/85c29c90-959f-482b-bf49-293163126609?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68080800",
"date_amm": "1996-07-24",
"type_amm": "Procédure nationale",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about AETOXISCLEROL.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.